CrowdfundedWealth

Madara AI & Frontier Technologies Fund (MXAI): Fees Left Blank

ResearchBy Jorge22 min read2 SEC filings cited

Some links pay us a referral fee; each one says so. Disclosure

Filing alert · free

An email when Madara AI & Frontier Technologies Fund files with the SEC

An email the day Madara AI & Frontier Technologies Fund files something new, with the link to the document on the SEC site.

Quick answer

As of November 20, 2026, Madara AI & Frontier Technologies Fund (CIK 2160391, San Francisco) is a proposed, not yet effective, NYSE-listed closed-end fund that would invest in other managers’ private AI and technology funds, not in AI companies directly. Its only filings on EDGAR are a Form N-8A and a Form N-2, both dated October 23, 2026. The prospectus says it expects to list under the symbol “MXAI,” and that buyers in the offering pay no sales load because the adviser pays it. It is not an interval fund and not a tender-offer fund: the filing says shareholders have no right to redeem and the fund has adopted no repurchase policy. The numbers that would let you price it are still blank: the management fee, other expenses, acquired fund fees, the total expense ratio and the offering price are all “[•]”. The fund’s only holder today is its adviser, which put in $100,000.

Key takeaways

  • Structure: a Delaware statutory trust formed on October 9, 2026, registered as a non-diversified closed-end fund that “operates as a fund of funds.” The Interval Fund box on the N-2 cover is not ticked, so there is no quarterly or semi-annual repurchase offer to count on.
  • What it would buy: at least 80% of its Assets in AI and frontier technology investments, mainly limited partner stakes in venture, growth and private equity funds run by other managers, bought as new commitments, as secondary purchases for cash, or in exchange for newly issued fund shares. The filing expects 20 or more such funds and sets no cap on how much goes into any one of them.
  • Cost: buyers in the offering pay no sales load, and the adviser, not the fund, bears organizational and offering costs. But the management fee rate, other expenses, acquired fund fees and total annual expenses are all blank. The management fee is charged on Managed Assets, including cash held for drawdowns, and a second layer of fees sits inside the underlying funds.
  • Exit: the only way out is to sell on the NYSE at the market price, if the listing is approved. The prospectus warns that the shares may trade at a discount, and that the fund determines NAV only monthly, from underlying valuations reported quarterly and in arrears.
  • The in-kind contributions are the unusual part: the fund plans to issue shares to holders of existing private fund stakes at values that “will exceed the Public Offering Price,” set by the adviser, which is paid on the fund’s assets. Those shares carry a 180-day lock-up.
  • Who runs it: Madara Fund Advisors LLC was formed in 2026, says it manages no client assets other than the fund’s $100,000 of initial capital, and had a registration application with the SEC still pending in the filing. Two portfolio managers are named; the investment committee and the independent trustees are blank.

CSV · 62 rows

Madara AI & Frontier Technologies Fund: N-2 terms, fee table blanks, exit and in-kind contribution rules, October 23, 2026

62 rows from the fund’s Form N-2 and Form N-8A of October 23, 2026: structure, adviser, board, the fee table and what it leaves blank, exit terms, leverage limits, in-kind contributions and distributions.

What the fund is, and what it is not

A reader who sees “AI private companies fund” may expect a vehicle that holds stakes in AI companies, or an interval fund with scheduled repurchases. The N-2 describes something narrower. The fund is “a newly organized Delaware statutory trust that is registered under the Investment Company Act of 1940” and “operates as a fund of funds.” On the cover page, the box “Registered Closed-End Fund” is ticked and the box for an “Interval Fund” (a fund that makes periodic repurchase offers under Rule 23c-3) is not. The Business Development Company box is not ticked either.

The fund says it gets its interests in three ways: capital commitments to private funds that are raising money; the purchase of existing interests from other investors in privately negotiated deals for cash; and the acquisition of existing interests in exchange for newly issued common shares. The prospectus adds that in the early years it expects its portfolio to be built “primarily through Secondary Investments, including the in-kind contributions.” It may also hold some companies directly, but only through co-investments next to another manager or when a private fund hands out shares in kind, and it “does not acquire securities of operating companies directly as a matter of course.” The document names no company and no underlying fund.

How that compares with funds we have already read: Powerlaw Corp (PWRL) and Robinhood Ventures Fund I (RVI) are also registered closed-end funds whose shares trade on an exchange, and the Private Shares Fund is an interval fund that offers to buy back shares. The Fundrise Innovation Fund (VCX) is another listed fund with private-company exposure. Madara’s own risk section says its structure, “a listed, closed-end fund of privately offered funds,” has “limited precedent.”

QuestionWhat the N-2 saysWhere
Filing and dateForm N-2 and Form N-8A, both October 23, 2026; no later amendment on EDGAR on November 20, 2026EDGAR filing list
Is it effective?No. “Subject to Completion”; shares may not be sold until the registration statement is effectiveCover
TypeNon-diversified closed-end fund; fund of funds; Interval Fund box not tickedCover, Summary
ListingApplied to list on the NYSE as “MXAI”; approval is not guaranteedCover
ObjectiveLong-term capital appreciation; the Board can change it without a shareholder voteSummary
Main policyAt least 80% of Assets in AI and frontier technology investmentsSummary
Themes it listsAI and machine learning, cloud and data infrastructure, cybersecurity, semiconductors, robotics, fintech and software infrastructure, space and defense, tech-enabled life sciencesSummary
Number of underlying funds20 or more expected; no limit on any single fundStrategies
Fiscal yearEnds March 31Summary

The 80% policy is measured on “Assets,” defined as net assets plus borrowings for investment purposes. A private fund counts toward it if it is “predominantly focused on” AI and other frontier technologies, which the fund decides from the underlying fund’s own stated mandate and not from the companies it actually holds. That matters for a reader who wants AI exposure specifically: the filing says it does not manage to a target between AI and other frontier technologies, because “AI is increasingly embedded within other frontier technologies.”

Who runs it

The adviser is Madara Fund Advisors LLC, 505 Montgomery Street, Suite 1100, San Francisco. The prospectus says it is a Delaware limited liability company formed in 2026, that its application to register as an investment adviser with the SEC is pending, and that “As of the date of this Prospectus, the Adviser does not manage any client assets other than the Fund’s initial capital.” The Form ADV file number is blank, so the adviser’s regulatory assets and any disciplinary disclosures cannot be checked yet. We will look them up once the registration is effective.

RoleWho the filing namesWhat the filing says
Portfolio Manager, founder and CEO of the adviserRobert GhenchevManaging Partner at Novo Holdings A/S from 2018 to 2025; earlier in healthcare investment banking at Moelis & Company and in mergers and acquisitions at Deutsche Bank. Also the fund’s Chair, CEO, President and Secretary, and its only interested trustee
Portfolio Manager, Managing Director, Sourcing and InvestmentsHamed AlamInvestment professional at Coller Capital, a global secondaries firm, from 2021 to 2024; Portfolio Manager at Tap Capital LLC from 2025 to 2026
Investment committeeblankThe paragraph describing the committee is in brackets, with “[•]” for its members, the votes required and its meetings
Independent trusteesblankThree seats shown, with names, birth years and biographies left as “[•]”
Treasurer and Chief Compliance Officeremployees of ACA GroupNot employees of the adviser; ACA Group provides financial, treasury and compliance officer services
Administrator, custodian, transfer agent, underwritersblankEach shown as “[•]”

Three points follow from this table. First, the person who founded the adviser also chairs the board and is the fund’s only interested trustee, with three independent trustees still unnamed. Second, the adviser has no record of its own: it was formed in 2026 and has managed only $100,000. Third, the portfolio managers’ backgrounds, on the filing’s account, are in growth investing and secondaries; the filing does not claim a record running a registered fund.

The fee stack: what is filled in and what is blank

The prospectus tells buyers in the offering that they “will not be charged a sales load.” The adviser pays the underwriters “from its own assets” and the fund will not repay it. The adviser also bears the fund’s organizational expenses and the offering costs under an expense assumption agreement, whose form is to be filed by amendment. That is the good news. The rest of the fee table is empty.

LayerWhat the N-2 saysFigure in the filing
Sales load to buyers in the offeringNone; paid by the adviser from its own assetsNone
Organization and offering costsBorne by the adviser, not reimbursed by the fundNone to the fund
Investment Management FeeAnnualized rate on Managed Assets, accrued monthly in arrears; Managed Assets include borrowings and cash[•]%
Interest on borrowed fundsThe table assumes no leverage0.00%
Other expensesAdministrator, transfer agent, custodian, professional fees, valuation costs, and contribution costs repaid to the adviser only if a contribution closes[•]%
Acquired fund fees and expensesAsset-based fees of the underlying funds; excludes their performance fees and allocations[•]%
Total annual expensesSum of the above[•]%
Underlying funds’ performance feesPaid by the underlying funds to their managers, outside the fee table[•]% to [•]% of net profits
SEC example cost per $1,000 (1, 3, 5, 10 years)Required by the SEC for every registered fund$[•] in every period

Four things to read from it.

There is no fund-level performance fee in the table. The performance fees the N-2 describes are the ones the underlying managers charge. The prospectus says an underlying manager “may therefore receive a performance fee or allocation” even in a period when other underlying funds lost money and the fund’s NAV fell, because the fund “cannot offset a gain at one Underlying Fund against a loss at another.”

The management fee is charged on cash. The use-of-proceeds section says that because the fee “accrues on the Fund’s Managed Assets, which include cash and cash equivalents held pending drawdown,” the fund “pays the Investment Management Fee on that cash,” and unfunded commitments make that cash “an ongoing feature of the Fund’s structure.” The fund expects to commit substantially all proceeds within about 12 months of closing.

Leverage raises the fee as a share of your money. The fee base is Managed Assets, not net assets. If the fund borrowed the maximum the prospectus describes for debt, one-third of total assets, then for each $100 of net assets the fee base would be $150, so the fee would be 1.5 times the contractual rate measured on net assets (our arithmetic, from the 300% asset coverage rule the prospectus states). The prospectus says the fund does not presently intend to use leverage in its current fiscal year.

The blank cells are the whole decision. With no management fee rate, no acquired fund fee and no total, no worked example for $100,000 held for a year can be built from the filing, and we do not fill the blanks with guesses. The comparison to make, once an amendment fills the table, is the total annual expense line plus the underlying funds’ performance fees, which the table does not include.

How you get out

The N-2 is blunt about this. Under “Repurchase of Common Shares” it says “Common Shareholders do not have the right to require the Fund to redeem their Common Shares.” The Board “may (but is not obligated to)” repurchase shares in the open market or make tender offers, and the filing adds that “The Fund has not adopted any such policy” setting out when it would. That is the opposite of the interval funds we cover, where repurchase offers are a rule of the fund.

Exit questionWhat the N-2 says
Can you ask the fund to buy your shares?No. No right of redemption; no repurchase policy adopted
Where could you sell?On the NYSE, if the listing is approved; the prospectus says there is “no guarantee” of approval and that an active market “may not develop or be sustained”
At what price?The market price, which the prospectus says may be a discount to NAV; it warns the discount risk may be greater for those who sell soon after the offering
How often is NAV set?Monthly, at the last business day of each month, and on other dates the Board or adviser chooses
When is NAV published?The fund “expects to publish” it on madarafunds.com within ten business days of each date, but is not obligated to
How current is the NAV?Underlying managers report valuations quarterly “and with a substantial reporting lag”
Open-market buybacksSection 23(c)(1) of the 1940 Act lets the fund buy on the market only if it has told shareholders of its intention within the previous six months
Selling by in-kind shareholdersShares issued for contributed interests are restricted securities with a 180-day lock-up after the later of issuance and the offering closing

Valuation is also the adviser’s job. The Board has designated the adviser as the valuation designee under Rule 2a-5, and the prospectus lists as a conflict that “The Adviser determines the value of the Fund’s investments and is paid on the value it determines.” For most of the portfolio the adviser “generally uses the NAV reported by the general partner or manager of that Underlying Fund,” adjusted for later cash flows and events. A monthly NAV built on quarterly figures that arrive 60 days or more after quarter end is a number that moves slowly while the share price moves daily. The fund also says it will publish, at least quarterly, an “Exposure Report” of its principal indirect exposures to companies, and warns that it is an approximation.

The in-kind contributions: shares issued for private fund stakes

This is the feature that sets Madara’s N-2 apart from a plain fund of funds. The prospectus says the fund “plans on issuing Common Shares in exchange for existing interests in Underlying Funds under contribution agreements the Fund has entered into with holders of those interests.” It does not say who the contributors are or how many there are, and the form of contribution agreement is among the exhibits “to be filed by amendment.”

Term of an in-kind contributionWhat the N-2 says
What the contributor getsNewly issued common shares, in a private placement under Securities Act Section 4(a)(2) and Regulation D, to accredited investors; not part of this offering
Price per shareA value agreed in each contribution agreement that “will exceed the Public Offering Price”; the fund’s stated policy is never below the most recent NAV
Who sets the value of the contributed stakeThe adviser, “with the assistance of an independent third-party valuation firm,” and the adviser is paid on the fund’s assets
Effect on NAV for offering buyersNAV per share “is expected to increase relative to the Public Offering Price” right after the closings, if the offering and every contribution close
Limit per contributorNo issuance if the contributor and its affiliates would then own more than 25% of the shares
Unfunded commitmentsThe fund takes on any remaining commitment to call capital; the stated value reflects it
CostsPaid first by the adviser; repaid by the fund only if that contribution closes
Lock-up180 days after the later of issuance and the offering closing

For a buyer in the offering, there are two sides. The upside the prospectus points to is that contributed stakes are valued above the offering price, which would lift NAV per share immediately after closing, and “That increase would accrue to investors purchasing Common Shares in this offering.” The caution it attaches is that the increase “depends on the value attributed to the contributed interest being accurate,” and that an increase in NAV recognized at the time of acquisition “may correspondingly reduce the Fund’s reported investment performance in later periods.” The adviser sets those values and earns its fee on them, so the check is the independent valuation, which the filing does not include.

The sellers are also future holders: contributors receive shares that, after 180 days, “may be sold” on the exchange, a supply of stock that offering buyers do not have. The prospectus lists that eventual sale among the in-kind contribution risks.

Leverage, distributions and control

Leverage. The fund “does not presently intend to use leverage during its current fiscal year” and has “no credit facility or other borrowing arrangement in place.” The 1940 Act limits (as the prospectus states) debt to 300% asset coverage, which means one-third of total assets, and preferred shares to 200% coverage; holders of any preferred shares would elect two trustees.

Distributions. The fund intends to qualify as a regulated investment company and to declare distributions of income and net long-term gains “at least annually,” with no target rate. It may pay them from offering proceeds or borrowings. It may also declare a distribution payable, at each shareholder’s election, in cash or in shares, with the cash capped at “not less than 20%” of the declared amount. As an illustration (our arithmetic): on a declared $1,000,000 distribution, the fund could limit total cash to as little as $200,000, so a holder who elects cash could receive part of it in shares. Those shares are priced off the market price, may be issued below NAV, and, because the management fee is on Managed Assets, raise the adviser’s fee compared with an all-cash payment. Section 23(b) of the 1940 Act prohibits selling shares below NAV except in limited circumstances, and the prospectus says that prohibition does not restrict shares issued in payment of a distribution.

Control and governance. The board is split into three classes with staggered three-year terms. The bracketed text says a trustee can be removed only for cause by holders of at least 75% of the shares. The fund says the Delaware control share statute applies automatically, with voting thresholds of 10%, 15%, 20%, 25% and 30%, so a holder crossing a threshold may hold shares that carry no vote unless the board exempts the acquisition or other holders approve. The prospectus says these provisions “may have the effect of discouraging, delaying or preventing a change of control.”

What the filing still leaves blank

A first N-2 is a draft. Most of what a buyer needs is bracketed, and an amendment will fill it.

ItemIn the October 23, 2026 N-2Why it matters
Offering size and price per share[•]Sets the fund’s net assets, and every percentage in the fee table
Management fee rate[•]% of Managed AssetsThe largest fund-level cost
Other expenses, acquired fund fees, total expenses[•]%The all-in cost before the underlying funds’ performance fees
Underwriters and structuring fee recipient[•]Who sells it and who the adviser pays
Letters of interest to buy secondaries[•] underlying funds, bracketedWhether a first portfolio is already lined up
Independent trustees and investment committee[•]Who oversees the adviser’s valuations
Adviser’s Form ADV number801-[•]; registration pendingIts assets and any disciplinary history
Contribution agreements, advisory agreement and expense assumption agreementExhibits to be filed by amendmentThe contributors, their prices and what the adviser will bear
Financial statementsNone; to be filed by amendmentShows the $100,000 seed and net worth requirement

What a reader can do with this

  • If you saw the fund on a platform or in a pitch: it cannot be bought yet. The registration is not effective, the offering price is blank and the NYSE has not approved the listing.
  • Read the amendment, not the pitch. Open the next N-2/A on EDGAR (CIK 2160391) and look first at the management fee rate, “Total Annual Expenses,” the $1,000 example and the name of each contributor.
  • Price the exit before you size it. There is no redemption right and no repurchase policy. Whatever you buy can only be sold on the exchange at the market price, which may sit below NAV.
  • Compare what is comparable. For AI exposure through other structures see PWRL, RVI, VCX and the Private Shares Fund, and our explainer on what an interval fund is.
  • Ask who values the contributed stakes and whether the independent valuation can be read, since the adviser is paid on the fund’s assets.
  • Remember the second fee layer. The underlying managers’ performance fees are outside the expense table.

FAQ

All figures are from the filings of Madara AI & Frontier Technologies Fund (CIK 2160391) read on EDGAR on November 20, 2026: Form N-2 (accession 0002160391-26-000004) and Form N-8A (accession 0002160391-26-000002), both filed October 23, 2026; EDGAR lists no other filing by the fund. The one-and-a-half-times fee-base illustration and the $200,000 cash illustration are our arithmetic. This is analysis of public documents, not investment, legal or tax advice.

Affiliate Disclosure: Some links are affiliate links. We may earn a commission at no extra cost to you. This does not affect our ratings. Learn more.